Company News: Pfizer and GSK

Share this article:

Pfizer said its full-year 2009 revenues rose 4% to $50 billion, with US revenues up 7% over 2008 to $21.7 billion and international revenues up 1% to $28.3 billion. Fourth-quarter US revenues were up 42% compared to Q4 2008, while international revenues were up 28%.

GlaxoSmithKline announced its annual results, showing 3% sales growth for 2009, with sales from “white pills in western markets” down to 30% of full-year sales from 2008's 36%. Emerging markets sales were up 20%, while sales in Japan were up 22% and consumer healthcare product sales rose 7%. The company also announced the launch of a new specialist unit to research and develop drugs for rare diseases.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.